Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,054,674
-
Total 13F shares
-
71,584,721
-
Share change
-
+230,188
-
Total reported value
-
$977,803,865
-
Put/Call ratio
-
42%
-
Price per share
-
$13.66
-
Number of holders
-
144
-
Value change
-
-$10,119,008
-
Number of buys
-
72
-
Number of sells
-
56
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2022
As of 30 Sep 2022,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,584,721 shares.
The largest 10 holders included
EcoR1 Capital, LLC, BlackRock Inc., STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, Avoro Capital Advisors LLC, Holocene Advisors, LP, VANGUARD GROUP INC, BVF INC/IL, Deep Track Capital, LP, and T. Rowe Price Investment Management, Inc..
This page lists
144
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.